Von Hippel-Lindau (VHL) disease is a rare disorder characterized by the development of benign and malignant tumors and cysts in numerous organs/systems. Due to the rarity of VHL disease and limited awareness of its clinical signs, symptoms, and diagnostic workup, diagnosis is often delayed. This delay gains even greater significance in the current era now that systemic therapy is available for certain types of VHL disease-associated tumors. Tune in to this video-based activity as leading experts discuss strategies to proactively identify and care for patients with VHL disease-associated malignancies, inclusive of the latest clinical evidence and guidelines.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/expert-insight-into-von-hippel-lindau-vhl-disease-symptoms-diagnosis-cutting
- Start Date: 2024-02-29 06:00:00
- End Date: 2024-02-29 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: Merck (Any division) - Amount: 33166.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest